PERSPECTA

News from every angle

← Back to headlines

OraSure Projects H2 2026 Revenue Growth with New FDA-Submitted Diagnostics

OraSure Technologies anticipates a significant revenue increase in the second half of 2026, driven by the planned launch of two new diagnostic products that have been submitted to the FDA.

26 Feb, 01:18 — 26 Feb, 01:18
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha3h ago

OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches

Read full article →

Related Stories

Red tide returns to western Pangasinan, says BFAR

just now

Finns Studying Medicine Abroad Contribute to Potential Doctor Over-supply

21m ago

Proposal to Allow Pharmacists and Nurses to Issue Prescriptions Divides Hungarian Healthcare

24m ago

New Study Confirms Long-Term Efficacy of HPV Vaccine

27m ago